| Literature DB >> 25803304 |
E Michael Lewiecki1, John P Bilezikian, Neil Binkley, Didier Hans, Diane Krueger, Paul D Miller, Mary Oates, Elizabeth Shane.
Abstract
The 2014 Santa Fe Bone Symposium provided a setting for the presentation and discussion of the clinical relevance of recent advances in the fields of osteoporosis and metabolic bone disease. The format included oral presentations of abstracts by endocrinology fellows, plenary lectures, panel discussions and breakout sessions, with ample opportunities for informal discussions before and after scheduled events. Topics addressed in these proceedings included a review of the important scientific publications in the past year, fracture prevention in patients with dysmobility and immobility, fracture liaison services for secondary fracture prevention, management of pre-menopausal osteoporosis, the role of bone microarchitecture in determining bone strength, measurement of microarchitecture in clinical practice and methods to improve the quality of bone density testing. This is a report of the proceedings of the 2014 Santa Fe Bone Symposium.Entities:
Keywords: Controversy; emerging; guidelines; new; osteoporosis; risk; safety; treatment
Mesh:
Year: 2015 PMID: 25803304 DOI: 10.3109/07435800.2015.1005746
Source DB: PubMed Journal: Endocr Res ISSN: 0743-5800 Impact factor: 1.720